SK-0403

DRUG3 trials

Sponsors

Sanwa Kagaku Kenkyusho Co., Ltd., Kowa Research Institute, Inc.

Conditions

Type 2 DiabetesType 2 Diabetes Mellitus

Phase 1

A Multicenter, Open Label, Single Dose Study to Evaluate the Effect of Renal Insufficiency on the Pharmacokinetics of SK 0403

CompletedNCT01131091

Kowa Research Institute, Inc.Type 2 Diabetes Mellitus

Start: 2010-05-31End: 2010-11-30Target: 30Updated: 2011-02-10

Phase 2

Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus

CompletedNCT00532506

Sanwa Kagaku Kenkyusho Co., Ltd.Type 2 Diabetes Mellitus

Updated: 2008-10-10

A Study Comparing the Safety, Tolerance, and Efficacy of Various Doses of SK-0403 Versus Placebo and Sitagliptin 100 mg in Patients Not Well-Controlled on Metformin Therapy

CompletedNCT01169090

Kowa Research Institute, Inc.Type 2 Diabetes

Start: 2010-07-31End: 2011-08-31Target: 620Updated: 2011-08-17